Haemophilia. 2003 May;9(3):245-50.

A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community.

Source

Bayer Biological Products, 4101 Research Commons, Alexander Drive, Research Triangle Park, NC 27709-3387, USA. jeff.stonebraker.b@bayer.com

Abstract

The article presents a method to estimate the level of factor VIII (FVIII) concentrate consumption and economic capacity for each of the 110 countries considered in the study. A number of health-economic indicators were examined and purchasing power parity (PPP) gross national income (GNI) per capita had the strongest correlation with amount of FVIII concentrates sold in a country. Available data on FVIII concentrate consumption and health-economic indicators were used to calculate index values for FVIII use and economic capacity so each country can assess and compare its level of FVIII concentrate consumption with the economic resources of other countries in the global haemophilia A community. This article is of importance to policy makers, care givers and patient organizations in planning health-care resources for the treatment of haemophilia.

PMID:: 12694513; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Factor VIII

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Hemophilia - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

A study of reported factor VIII use around the world. [Haemophilia. 2010]
A study of reported factor VIII use around the world.
Stonebraker JS, Brooker M, Amand RE, Farrugia A, Srivastava A. Haemophilia. 2010 Jan; 16(1):33-46. Epub 2009 Oct 21.
A study of reported factor IX use around the world. [Haemophilia. 2011]
A study of reported factor IX use around the world.
Stonebraker JS, Bolton-Maggs PH, Brooker M, Farrugia A, Srivastava A. Haemophilia. 2011 May; 17(3):446-55. Epub 2011 Feb 7.
Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand. [Haemophilia. 2004]
Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand.
Stonebraker JS, Amand RE, Bauman MV, Nagle AJ, Larson PJ. Haemophilia. 2004 Jan; 10(1):18-26.
Review Treating haemophilia A with recombinant blood factors: a comparison. [Expert Opin Pharmacother. 2004]
Review Treating haemophilia A with recombinant blood factors: a comparison.
Ananyeva N, Khrenov A, Darr F, Summers R, Sarafanov A, Saenko E. Expert Opin Pharmacother. 2004 May; 5(5):1061-70.
Review Inhibitors in haemophilia A: current management and open issues. [Haemophilia. 2007]
Review Inhibitors in haemophilia A: current management and open issues.
Haya S, Moret A, Cid AR, Cortina V, Casaña P, Cabrera N, Aznar JA. Haemophilia. 2007 Dec; 13 Suppl 5:52-60.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

A country-by-country comparison of FVIII concentrate consumption and economic ca...
A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community.
Haemophilia. 2003 May ;9(3):245-50.

PubMed
Intranigral infusion of interleukin-1beta activates astrocytes and protects from...
Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.
J Neurochem. 2003 May ;85(3):651-61.

PubMed
Subdivision and haplotype structure in natural populations of Arabidopsis lyrata...
Subdivision and haplotype structure in natural populations of Arabidopsis lyrata.
Mol Ecol. 2003 May ;12(5):1247-63.

PubMed
Two novel mutations in the alpha-galactosidase A gene in Chinese patients with F...
Two novel mutations in the alpha-galactosidase A gene in Chinese patients with Fabry disease.
Clin Genet. 2003 Mar ;63(3):205-9.

PubMed
Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effe...
Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane.
Biochemistry (Mosc). 2003 Feb ;68(2):217-27.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: